These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29717446)
1. Detection of Cancer DNA in Early Stage and Metastatic Breast Cancer Patients. Medford AJ; Gillani RN; Park BH Methods Mol Biol; 2018; 1768():209-227. PubMed ID: 29717446 [TBL] [Abstract][Full Text] [Related]
2. Detection of circulating tumor DNA (ctDNA) by digital droplet polymerase chain reaction (dd-PCR) in liquid biopsies. Valpione S; Campana L Methods Enzymol; 2019; 629():1-15. PubMed ID: 31727235 [TBL] [Abstract][Full Text] [Related]
3. Detection of cancer DNA in plasma of patients with early-stage breast cancer. Beaver JA; Jelovac D; Balukrishna S; Cochran R; Croessmann S; Zabransky DJ; Wong HY; Toro PV; Cidado J; Blair BG; Chu D; Burns T; Higgins MJ; Stearns V; Jacobs L; Habibi M; Lange J; Hurley PJ; Lauring J; VanDenBerg D; Kessler J; Jeter S; Samuels ML; Maar D; Cope L; Cimino-Mathews A; Argani P; Wolff AC; Park BH Clin Cancer Res; 2014 May; 20(10):2643-2650. PubMed ID: 24504125 [TBL] [Abstract][Full Text] [Related]
4. Identification and Use of Personalized Genomic Markers for Monitoring Circulating Tumor DNA. Chen Y; George AM; Olsson E; Saal LH Methods Mol Biol; 2018; 1768():303-322. PubMed ID: 29717450 [TBL] [Abstract][Full Text] [Related]
5. Monitoring of Response and Resistance in Plasma of EGFR-Mutant Lung Cancer Using Droplet Digital PCR. Kuang Y; O'Connell A; Sacher AG; Feeney N; Alden RS; Oxnard GR; Paweletz CP Methods Mol Biol; 2018; 1768():193-207. PubMed ID: 29717445 [TBL] [Abstract][Full Text] [Related]
6. Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer. Kodahl AR; Ehmsen S; Pallisgaard N; Jylling AMB; Jensen JD; Laenkholm AV; Knoop AS; Ditzel HJ Mol Oncol; 2018 Jun; 12(6):925-935. PubMed ID: 29689598 [TBL] [Abstract][Full Text] [Related]
7. Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer. Christensen E; Birkenkamp-Demtröder K; Nordentoft I; Høyer S; van der Keur K; van Kessel K; Zwarthoff E; Agerbæk M; Ørntoft TF; Jensen JB; Dyrskjøt L Eur Urol; 2017 Jun; 71(6):961-969. PubMed ID: 28069289 [TBL] [Abstract][Full Text] [Related]
8. Preanalytical blood sample workup for cell-free DNA analysis using Droplet Digital PCR for future molecular cancer diagnostics. van Ginkel JH; van den Broek DA; van Kuik J; Linders D; de Weger R; Willems SM; Huibers MMH Cancer Med; 2017 Oct; 6(10):2297-2307. PubMed ID: 28940814 [TBL] [Abstract][Full Text] [Related]
9. Comparison of BEAMing and Droplet Digital PCR for Circulating Tumor DNA Analysis. O'Leary B; Hrebien S; Beaney M; Fribbens C; Garcia-Murillas I; Jiang J; Li Y; Huang Bartlett C; André F; Loibl S; Loi S; Cristofanilli M; Turner NC Clin Chem; 2019 Nov; 65(11):1405-1413. PubMed ID: 31551314 [TBL] [Abstract][Full Text] [Related]
10. Monitoring Melanoma Using Circulating Free DNA. Diefenbach RJ; Lee JH; Rizos H Am J Clin Dermatol; 2019 Feb; 20(1):1-12. PubMed ID: 30374893 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients. Sánchez-Martín V; López-López E; Reguero-Paredes D; Godoy-Ortiz A; Domínguez-Recio ME; Jiménez-Rodríguez B; Alba-Bernal A; Elena Quirós-Ortega M; Roldán-Díaz MD; Velasco-Suelto J; Linares-Valencia N; Garrido-Aranda A; Lavado-Valenzuela R; Álvarez M; Pascual J; Alba E; Comino-Méndez I Clin Chim Acta; 2024 Jan; 552():117673. PubMed ID: 38007055 [TBL] [Abstract][Full Text] [Related]
12. DNA Methylation Analysis Using Droplet Digital PCR. Yu M; Heinzerling TJ; Grady WM Methods Mol Biol; 2018; 1768():363-383. PubMed ID: 29717454 [TBL] [Abstract][Full Text] [Related]
14. Treatment and relapse in breast cancer show significant correlations to noninvasive testing using urinary and plasma DNA. Zhang J; Zhang X; Shen S Future Oncol; 2020 May; 16(13):849-858. PubMed ID: 32270709 [No Abstract] [Full Text] [Related]
15. Microarray Approach Combined with ddPCR: An Useful Pipeline for the Detection and Quantification of Circulating Tumour dna Mutations. Galbiati S; Damin F; Ferraro L; Soriani N; Burgio V; Ronzoni M; Gianni L; Ferrari M; Chiari M Cells; 2019 Jul; 8(8):. PubMed ID: 31344983 [No Abstract] [Full Text] [Related]
17. Detection of Olmedillas-López S; Lévano-Linares DC; Alexandre CLA; Vega-Clemente L; Sánchez EL; Villagrasa A; Ruíz-Tovar J; García-Arranz M; García-Olmo D World J Gastroenterol; 2017 Oct; 23(39):7087-7097. PubMed ID: 29093617 [TBL] [Abstract][Full Text] [Related]
18. Aberrantly Methylated cfDNA in Body Fluids as a Promising Diagnostic Tool for Early Detection of Breast Cancer. Stastny I; Zubor P; Kajo K; Kubatka P; Golubnitschaja O; Dankova Z Clin Breast Cancer; 2020 Dec; 20(6):e711-e722. PubMed ID: 32792225 [TBL] [Abstract][Full Text] [Related]
19. Identification of E545k mutation in plasma from a PIK3CA wild-type metastatic breast cancer patient by array-based digital polymerase chain reaction: Circulating-free DNA a powerful tool for biomarker testing in advance disease. Romero A; Acosta-Eyzaguirre D; Sanz J; Moreno F; Serrano G; Díaz-Rubio E; Caldés T; Garcia-Saenz JÁ Transl Res; 2015 Dec; 166(6):783-7. PubMed ID: 26001593 [TBL] [Abstract][Full Text] [Related]
20. Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review. Olmedillas-López S; Olivera-Salazar R; García-Arranz M; García-Olmo D Mol Diagn Ther; 2022 Jan; 26(1):61-87. PubMed ID: 34773243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]